Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04503096 · ClinicalTrials.gov registry record · NA

Plasticity Using Stimulation and Habit: A Pilot Open-label rTMS Study for MCI

A NA study, sponsored by Medical University of South Carolina.

Completed
Registry status
NA
Development phase
24
Enrollment target

NCT04503096: Completed NA study, sponsored by Medical University of South Carolina.

NCT04503096 is a NA study that has completed, run by Medical University of South Carolina. The registered enrollment target is 24 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04503096, a NA study, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target

Study Summary

The goal of this pilot study is to determine whether a high-dose form of non-invasive brain stimulation is a promising and safe treatment for Mild Cognitive Impairment (MCI). Transcranial magnetic stimulation (TMS) is an FDA approved treatment for depression. In studies of TMS for depression and other disorders, individuals have experienced improved cognitive function. Thus, the current study is testing whether TMS is safe, feasible and effective in improving cognition in individuals with MCI.

Primary Outcome

Clinically significant structural brain change were determined by a board-certified neuroradiologist who reviewed both the pre-treatment and post-treatment structural (T1- and T2-weighted) MRI scans to identify the presence of any changes from pre- to post-treatment based on their clinical read of the images.

Interventions

  • DEVICE High-dose accelerated rTMS

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2021-04-12
Est. Completion 2022-07-27
Phase NA

What the finished NCT04503096 record still lists

NCT04503096 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which High-dose accelerated rTMS is the first listed.

NCT04503096 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04503096 about?

NCT04503096 is a clinical study titled "Plasticity Using Stimulation and Habit: A Pilot Open-label rTMS Study for MCI". The goal of this pilot study is to determine whether a high-dose form of non-invasive brain stimulation is a promising and safe treatment for Mild Cognitive Impairment (MCI). Transcranial magnetic stimulation (TMS) is an FDA approved treatment for depression. In studies of TMS for depression and oth...

What is the current status of trial NCT04503096?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2021-04-12. Estimated completion is 2022-07-27.

What interventions are being tested in trial NCT04503096?

The interventions under investigation include: High-dose accelerated rTMS (DEVICE).

Who is sponsoring clinical trial NCT04503096?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04503096's enrollment target sits among peer trials

24 1736th of 2000 higher than 246 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04503096, the US trial registry maintained by the National Library of Medicine. NCT04503096 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.